Vitamin K status of preterm infants with a prolonged prothrombin time

Acta Paediatr. 2005 Dec;94(12):1822-4. doi: 10.1111/j.1651-2227.2005.tb01859.x.

Abstract

Aim: To investigate the vitamin K status of preterm infants who have a prolonged prothrombin time (PT) in the first month of life.

Methods: Measures of vitamin K status were assessed in 21 preterm infants who were found to have an abnormal PT, despite 0.2-0.5 mg vitamin K(1) prophylaxis at birth.

Results: All infants had normal or supraphysiological vitamin K(1) concentrations and undetectable or, in one infant, insignificant PIVKA-II, indicating adequate vitamin K status.

Conclusion: In preterm infants born at <32 wk gestation who received > or = 0.2 mg vitamin K(1) after delivery, a prolonged PT in the first month of life is unlikely to be due to vitamin K deficiency.

MeSH terms

  • Biomarkers / blood
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Protein Precursors / blood
  • Prothrombin
  • Prothrombin Time
  • Randomized Controlled Trials as Topic
  • Vitamin K 1 / blood
  • Vitamin K 1 / therapeutic use
  • Vitamin K Deficiency / drug therapy
  • Vitamin K Deficiency / physiopathology*
  • Vitamins / therapeutic use

Substances

  • Biomarkers
  • Protein Precursors
  • Vitamins
  • acarboxyprothrombin
  • Vitamin K 1
  • Prothrombin